Round Table on Economics and Access, Health Care Systems and Novel Therapies’
As with every change, moving forward with EHLs, novel non-factor replacement treatments and gene therapy will require, in the first place, education for patients, doctors, policy-makers, pharmaceutical companies and health care workers. Join this network of education through this Round Table report and presentations.
EHC 2018: Changes, updates and highlights – EHC May Newsletter
This issue is a compilation of all EHC NOW! materials published between January and April; in its pages, you will find an introduction to the changes taking place within the organisation, future plans (such as eradicating HCV from the haemophilia community by 2022) and highlights from important for-the-community events.
Go inside the realities of day-to-day life of people with haemophilia and inhibitors. Hear their stories and experience what different outcomes disparities in access to treatment throughout Europe lead to.
The EHC publishes a newsletter three times a year (April, August, December) with information about its activities, news from its members and other hot topics from the European bleeding disorders’ community.